The US anal fistula drugs market is expected to grow at a significant CAGR during the forecast period. A tunnel or tract between the epithelial surface of the rectum or anus and the skin, which is the perianal area, is known as an anal fistula. Infection of this tract can result in edema, pus, and pain. A huge patient pool has resulted from the high incidence rate of anal fistula. Furthermore, an increase in the incidence of anal fistula-inducing co-morbidities such as Crohn’s disease, anal abscess, HIV, and tuberculosis infections has led to an increase in the number of complex anal fistula cases. The high prevalence of inflammatory bowel illnesses (IBD) such as Crohn’s disease and ulcerative colitis is also contributing to the growth of the market in the country.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-anal-fistula-drugs-market
According to the data released by the UCLA Center for IBD, in February 2019, around 1.6 million Americans were suffering from IBD and growing around 70,000 new cases each year. The people diagnosed majorly fell in the age group of 15-30 years. As per the study released by the American College of Gastroenterology, in 2019, around 10% – 15% out of the total adult population are suffering from IBS in the US. However, only 5% -7% have been diagnosed with IBS diseases among the adult population of the country. This, in turn, is driving the demand for anal fistula drugs such as laxatives, antibiotics, and calcium channel blockers, among others.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Takeda Pharmaceutical Co. Ltd., and Pfizer Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
United States Anal Fistula Drugs Market Report by Segment
By Type
- Laxatives
- Antibiotics
- Calcium Channel Blockers
- OnabotulinumtoxinA Injections
- Topical Nitrates
- Others
A full report of United States Anal Fistula Drugs Market is available at: https://www.omrglobal.com/industry-reports/us-anal-fistula-drugs-market
United States Anal Fistula Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Takeda Pharmaceutical Co. Ltd.
- Pfizer Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
